Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicrea To Pay $2M, Resolving Physician Kickback Claims

Executive Summary

Device company Medicrea, which was recently acquired by Medtronic, is paying $2m to resolve allegations the company violated both the False Claims Act and the Open Payments Program.

You may also be interested in...



Attorneys Predict Pandemic-Related Rise In False Claims Allegations

The Department of Justice may soon be busy with allegations of pandemic-related fraud and abuse, attorneys predicted in a recent conference presentation.

Medtronic Expands Spine Surgery Portfolio By Acquiring Medicrea

Medtronic has announced a deal to buy French spinal surgery company Medicrea for about €200m ($228m). The acquisition makes Medtronic the first company to offer an integrated AI-driven spinal surgery solution.

Physicians Failing To Disclose Supplier, POD Arrangements Fuel Kickback Concerns, Senators Say

US Senate Finance Committee leaders say some physicians may have failed to disclose their physician-ownership interests in entities that offer medical supplies to the physician’s own practice, as required under the Physician Payment Sunshine Act. The legislators on March 19 prodded the Health and Human Services' Office of Inspector General (OIG) and the Centers for Medicare and Medicaid Services (CMS) to take a closer look into these arrangements.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT143966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel